Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 25, 2023
0Patent Application Number
170945410
Date Filed
November 10, 2020
0Patent Citations
...
Patent Citations Received
Patent Primary Examiner
The present invention is the use of a small group of purine nucleotide phosphoramidate disclosed herein or a pharmaceutically acceptable salt thereof in an effective amount for the treatment or prevention of the novel 2019 coronavirus disease (COVID-19) in a host, for example a human, in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.